SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences informs about outcome of board meeting

28 Jan 2021 Evaluate

Eris Lifesciences has informed that the Board of Directors of the Company at their meeting held today, 28th January 2021 duly approved and took on record the limited reviewed Un-audited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results for the quarter and nine months ended 31st December 2020. The company has enclosed Un-audited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2020 along with the Limited Review Reports of the Auditors. The meeting of the Board of Directors commenced at 11:30 a.m. and concluded at 12:17 pm.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1446.50 -18.90 (-1.29%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×